Globally, the market for antidepressant drugs mask has been growing at a swift pace on the back of rising prevalence mental disorders, rising healthcare awareness and rising disposable incomes. Apart from these factors, rising healthcare facilities, increasing number of psychiatrist as well as surging number of hospital and clinics and burgeoning growth in Asia Pacific market is impelling growth in the market.

1. Global Antidepressant Drugs Market – Analysis By Drugs
Class, By Sales Channel, By Region, By Country:
Opportunities and Forecasts (2018-2023)
• By Drugs Class - Tricyclic Antidepressants, Selective
Serotonin Reuptake Inhibitors, Selective -Norepinephrine
Reuptake Inhibitors, Monoamine Oxidase Inhibitors ,
Benzodiazepines. Antipsychotics, Novel Agents
• By Sales Channel - Hospital & Clinics, Retail Pharmacies,
Others
• By Region- APAC , North America, Europe and RoW
• By Country - United States, Canada, United Kingdom,
Germany, , China, India, Japan, Brazil, South Arabia
February 2018

2. 2
 Anti Depressants Drugs Market –
By Value (In USD Billion) -(2013-
2023)
 By Drugs Class ( Tricyclic,
Serotonin-Norepinephrine
Inhibitors, Antipsychotics,
Selective Srotonin Reuptake
Inhibitors, Benzodiazepines,
Monoamine Oxidase Inhibitors,
Novel Agents, Others)
 By Sales Channels (Hospitals &
Clinics, Retail Pharmacies,
Others)
Global Coverage
Regional Coverage
Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By
Country: Opportunities and Forecasts (2018-2023) - By Region (APAC , N. America, Europe , RoW),
By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia)
 Antidepressant Drugs Market –
By Value (2013-2023)
 Segmentation By Drugs Class
 Segmentation By Sale
Channels
 North America
 Europe
 Asia Pacific
 Rest of World
Country Coverage
 Anti Depressant Drugs Market
– By Value (In USD Billion) -
(2013-2023)
 Breakdown-By - Drugs Class
(2013-2023)
 U.S.
 Canada
 Germany
 United Kingdom
 India
 China
 Japan
 Brazil
 South Arabia
Company Coverage
 PFIZER INC.
 ELI LILLY
 Allergan
 Novartis
 Takeda
 GlaxoSmithkiline
 Forest Laboratories
 Global Coverage
 Regional Coverage
 Country Coverage
Scope of the Study
 Region (North America, Europe, APAC, Rest of World )
 Country (U.S., Canada, Germany, United Kingdom,
India, China, Japan, Brazil, South Arabia)
 By Drugs Class
 By Sales Channels
 Product Benchmarking
 Business Overview
 Pipeline Analysis

3. Table of Content
S.No Particulars Page No.
1. Research Methodology 18
2. Executive Summary 19
3. Strategic Recommendation 20
3.1 Focus on Asia Pacific Region 21
3.2 Focus on new antidepressant drugs development 22
4. Antidepressant Drugs Market Outlook 23
5. Global Antidepressant Drugs Market: Growth and Forecast 28
5.1 By Value (2013-2017) 29
5.2 By Value (2018-2023) 34
6. Global Antidepressant Drugs Market: By Drugs Class 35
6.1 Global Antidepressant Drugs Market-By Drugs Class: Breakdown(%) 35
6.1.1 Global Antidepressant Drugs Market Size and Share, By Drugs, 2017 36
6.1.2 Global Antidepressant Drugs Market Size and Share, By Drugs, 2023 37
6.2 Global Selective Serotonin Reuptake Inhibitors Market Overview 38
6.2.1 By Value (2013-2023) 38
3

4. Table of Content
S. No Particulars Page No.
6.3 Global Serotonin and Norepinephrine Reuptake Inhibitors Market Overview 42
6.3.1 By Value (2013-2023) 42
6.4 Global Monoamine Oxidase Inhibitors Market Overview 44
6.4.1 By Value (2013-2023) 44
6.5 Global Tricyclic Antidepressant Drugs Market Overview 46
6.5.1 By Value (2013-2023) 46
6.6 Global Benzodiazepines Antidepressant Drugs Market Overview 48
6.6.1 By Value (2013-2023) 48
6.7 Global Antipsychotics Antidepressant Drugs Market Overview 50
6.7.1 By Value (2013-2023) 50
6.8 Global Novel Agents Antidepressant Drugs Market Overview 52
6.8.1 By Value (2013-2023) 52
6.9 Global Other Antidepressant Drugs Market Overview 53
6.9.1 By Value (2013-2023) 53
7. Global Antidepressant Drugs Market: By Sales Channels 54
7.1 Global Antidepressant Drugs Market-By Sales Channels : Breakdown(%) 54
7.1.1 Global Antidepressant Drugs Market Size and Share, By Sales Channels, 2017 55
7.1.2 Global Antidepressant Drugs Market Size and Share, By Sales Channels, 2023 56
4

5. Table of Content
S. No Particulars Page No.
7.2 Global Antidepressant Drugs Market By Hospital & Clinics Overview 57
7.2.1 By Value (2013-2023) 57
7.3 Global Antidepressant Drugs Market By Retail Pharmacies Overview 58
7.3.1 By Value (2013-2023) 58
7.4 Global Antidepressant Drugs Market By Others Overview 59
7.4.1 By Value (2013-2023) 59
8. Global Antidepressant Drugs Market: Pipeline Analysis 60
8.1 By Developer, Phase, Indication and Status 61
9. Global Antidepressant Drugs Market: Regional Analysis 65
9.1 Global Antidepressant Drugs Market, By Region: Breakdown (%) 65
9.1.1 Global Antidepressant Drugs Market Size, By Region, 2017 (%) 66
9.1.2 Global Antidepressant Drugs Market Size, By Region, 2023 (%) 67
9.2 North America Antidepressant Drugs Market: An Analysis 68
9.2.1 By Value (2013-2017) 69
9.2.2 By Value (2018-2023) 70
9.3 North America Antidepressant Drugs Market: Segment Analysis 71
9.3.1 North America Antidepressant Drugs Market: By Drug Class 72
9.3.1.1 North America Antidepressant Drugs Market Size, By Value, 2013-2023 72
9.3.2 North America Antidepressant Drugs Market: By Sales Channels 74
9.3.2.1 North America Antidepressant Drugs Market Size, By Value, 2013-2023F 75
5

6. Table of Content
S. No Particulars Page No.
9.4 North America Antidepressant Drugs Market: Country Analysis (U.S. and Canada) 76
9.4.1 U.S. Antidepressant Drugs Market, By Value (2013-2023) 79
9.4.1.1 U.S. Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 84
9.4.2 Canada Antidepressant Drugs Market, By Value (2013-2023) 87
9.4.2.2 Canada Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 89
9.5 Europe Antidepressant Drugs Market: An Analysis 91
9.5.1 By Value (2013-2017) 92
9.5.2 By Value (2018-2023) 93
9.6 Europe Antidepressant Drugs Market: Segment Analysis 94
9.6.1 Europe Antidepressant Drugs Market: By Drugs Class 94
9.6.1.1 Europe Antidepressant Drugs Market Size, By Value, 2013-2023 95
9.6.2 Europe Antidepressant Drugs Market: By Sales Channels 97
9.6.2.1 Europe Antidepressant Drugs Market Size, By Value, 2013-2023F 98
9.7 Europe Antidepressant Drugs Market: Country Analysis (U.K., Germany & Rest of Europe) 99
9.7.1 United Kingdom Antidepressant Drugs Market, By Value (2013-2023) 102
9.7.1.1 United Kingdom Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 106
9.7.2 Germany Antidepressant Drugs Market, By Value (2013-2023) 109
9.7.2.1 Germany Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 112
9.7.3 Rest of Europe Antidepressant Drugs Market, By Value (2013-2023) 114
6

7. Table of Content
S. No Particulars Page No.
9.8 Asia Pacific Antidepressant Drugs Market: An Analysis 115
9.8.1 By Value (2013-2017) 116
9.8.2 By Value (2018-2023) 117
9.9 Asia Pacific Antidepressant Drugs Market: Segment Analysis 118
9.9.1 Asia Pacific Antidepressant Drugs Market: By Drugs Class 118
9.9.1.1 Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2023 119
9.9.2 Asia Pacific Antidepressant Drugs Market: By Sales Channels 121
9.9.2.1 Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2023F 122
9.10 Asia Pacific Antidepressant Drugs Market: Country Analysis (Germany, U.K., & Rest of Europe) 123
9.10.1 India Antidepressant Drugs Market, By Value (2013-2023) 126
9.10.1.1 India Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 130
9.10.2 China Antidepressant Drugs Market, By Value (2013-2023) 133
9.10.2.1 China Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 136
9.10.3 Japan Antidepressant Drugs Market, By Value (2013-2023) 140
9.10.3.1 Japan Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 143
9.10.4 Rest of Asia Pacific Antidepressant Drugs Market, By Value (2013-2023) 145
7

8. Table of Content
S. No Particulars Page No.
9.11 Rest of World Antidepressant Drugs Market: An Analysis 146
9.11.1 By Value (2013-2017) 147
9.11.2 By Value (2018-2023) 148
9.12 Rest of World Antidepressant Drugs Market: Segment Analysis 149
9.12.1 Rest of World Antidepressant Drugs Market: By Drugs Class 149
9.12.1.1 Rest of World Antidepressant Drugs Market Size, By Value, 2013-2023 150
9.12.2 Rest of World Antidepressant Drugs Market: By Sales Channels 152
9.12.2.1 Rest of World Antidepressant Drugs Market Size, By Value, 2013-2023F 153
9.13 Rest of World Antidepressant Drugs Market: Country Analysis (Brazil, Saudi Arabia & Others) 154
9.13.1 Brazil Antidepressant Drugs Market, By Value (2013-2023) 157
9.13.1.1 Brazil Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 158
9.13.2 Saudi Arabia Antidepressant Drugs Market, By Value (2013-2023) 161
9.13.2.1 Saudi Arabia Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 162
9.13.3 Others Antidepressant Drugs Market, By Value (2013-2023) 164
8

9. Table of Content
S. No Particulars Page No.
10. Market Dynamics 165
10.1 Drivers 166
10.2 Challenges 169
11. Market Trends 171
12. Policy and Regulatory Landscape 173
13. Porter’s Five Forces Analysis – Antidepressant Drugs Market 181
14. SWOT Analysis –Antidepressant Drugs Market 183
15. Company Profiling 185
15.1 Allergan 186
15.2 Eli Lilly 187
15.3 Pfizer 188
15.4 Takeda 190
15.5 GlaxoSmithKline 192
15.6 Novartis 193
15.7 Forest Laboratories 195
16. About Us 196
9

10. List of Figures
Figure No. Figure Title Page No.
Figure 1: Global Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 29
Figure 2: Global YLDs of Depressive Disorders (2013-2016, %) 30
Figure 3: Global DALYs of Anxiety Disorders (2013-2016 %) 30
Figure 4: DALYs due to Mental and Substance Abuse (2016) 30
Figure 5: World Female Population, 2012-2016 (Million) 31
Figure 6: World Population 65 Years & Above (% of Total), 2012-2016 31
Figure 7: Global Unemployment (2016, 2017E, 2018F, (Millions) 32
Figure 8: Global Health Expenditure Per Capita, By Select Countries,(2016, USD) 33
Figure 9: Global Health Expenditure Per Capita, (2012-2016, USD Trillion) 33
Figure 10: Global Antidepressant Drugs Market Size, By Value, 2018-2023 (USD Billion) 34
Figure 11: Global Antidepressant Drugs Market Size, By Drugs, 2017 (%) 36
Figure 12: Global Antidepressant Drugs Market Size, By Drugs Class, 2023F (%) 37
Figure 13: Global Selective Serotonin Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD
Billion)
38
Figure 14: Global Selective Serotonin Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2018E-2023F (USD
Billion)
38
Figure 15: SSRIs Antidepressants Usage in Different Disorders (%) 40
Figure 16: Global Serotonin and Norepinephrine Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2013-2017
(USD Billion)
42
Figure 17: Global Serotonin and Norepinephrine Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2018E-
2023F (USD Billion)
42
Figure 18: Global Monoamine Oxidase Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 44
Figure 19: Global Monoamine Oxidase Inhibitors Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 44
10

11. List of Figures
Figure No. Figure Title Page No.
Figure 20: Global Tricyclic Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 46
Figure 21: Global Tricyclic Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 46
Figure 22: Global Benzodiazepines Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 48
Figure 23: Global Benzodiazepines Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 48
Figure 24: Global Antipsychotics Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 50
Figure 25: Global Antipsychotics Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 50
Figure 26: Global Novel Agents Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 52
Figure 27: Global Novel Agents Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 52
Figure 28: Global Others Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 53
Figure 29: Global Others Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 53
Figure 30: Global Antidepressant Drugs Market Size, By Sales Channels, 2017 (%) 55
Figure 31: Global Antidepressant Drugs Market Size, By Sales Channels, 2023 (%) 56
Figure 32: Global Antidepressant Drugs Market, By Hospital and Clinics, By Value, 2013-2017 (USD Billion) 57
Figure 33: Global Antidepressant Drugs Market, By Hospital and Clinics, By Value, 2018E-2023F (USD Billion) 57
Figure 34: Global Antidepressant Drugs Market, By Retail Pharmacies, By Value, 2013-2017 (USD Billion) 58
Figure 35: Global Antidepressant Drugs Market, By Retail Pharmacies, By Value, 2018E-2023F (USD Billion) 58
Figure 36: Global Antidepressant Drugs Market, By Others, By Value, 2013-2017 (USD Billion) 59
Figure 37: Global Antidepressant Drugs Market, By Others, By Value, 2018E-2023F (USD Billion) 59
Figure 38: Global Antidepressant Drugs Market Size and Share, By Region, 2017 66
Figure 39: Global Antidepressant Drugs Market Size and Share, By Region, 2023F 67
11

12. List of Figures
Figure No. Figure Title Page No.
Figure 40: North America Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 69
Figure 41: North America Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion) 70
Figure 42: North America Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 72
Figure 43: North America Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion) 75
Figure 44: North America Antidepressant Drugs Market, Country Share, 2017 (% of Total) 77
Figure 45: North America Antidepressant Drugs Market, Country Share, 2023 (% of Total) 77
Figure 46: United States Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 79
Figure 47: United States Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 79
Figure 48: United States YLDs by Anxiety Disorders (2013-2016 %) 80
Figure 49: United States YLDs by Depressive Disorders (2013-2016 %) 80
Figure 50: United States Prevalence of Different Types of Mental Disorders Among Different Age Group (2016) 80
Figure 51: United States Prevalence of Different Types of Mental Disorders Among Different Age Group (2016) 81
Figure 52: Treatment Received Among Adults with Major Depressive Episode (2016) 81
Figure 53: Per Capita Healthcare Expenditure in United States (2012-2016, USD) 82
Figure 54: U.S Health Spending by Type of Service or Product, 2016 (%) 82
Figure 55: U.S Health Spending by Type of Service or Product, 2016 (%) 84
Figure 56: Canada Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 87
Figure 57: Canada Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 87
Figure 58: Canada Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 89
Figure 59: Europe Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 92
Figure 60: Europe Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 93
12

13. List of Figures
Figure No. Figure Title Page No.
Figure 61: Europe Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 95
Figure 62: Europe Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion) 98
Figure 63: Europe Antidepressant Drugs Market, Country Share, 2017 (% of Total) 100
Figure 64: Europe Antidepressant Drugs Market, Country Share, 2023 (% of Total) 100
Figure 65: United Kingdom Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 102
Figure 66: United Kingdom Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 102
Figure 67: United Kingdom YLDs by Depressive Disorders (2013-2016 %) 103
Figure 68: Antidepressant Dispensed in England (2005, 2015, 2016, Million Units) 103
Figure 69: United Kingdom YLDs by Anxiety Disorders (2013-2016 %) 103
Figure 70: Per Capita Healthcare Expenditure in United Kingdom (2012-2016, USD) 104
Figure 71: U.K. Population 65 Years & Above (% of Total), 2012-2016 104
Figure 72: United Kingdom Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 106
Figure 73: Germany Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 109
Figure 74: Germany Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 109
Figure 75: Private Healthcare Spending in Germany, US Dollar/capita (2012-2016) 110
Figure 76: Germany Per Capita Healthcare Expenditure (2012-2016, USD) 110
Figure 77: Germany YLDs & DALYs by Depressive Disorders (2013-2016 %) 110
Figure 78: Germany Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 112
Figure 79: Rest of Europe Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 114
Figure 80: Rest of Europe Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 114
13

14. List of Figures
Figure No. Figure Title Page No.
Figure 81: Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 116
Figure 82: Asia Pacific Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion) 117
Figure 83: Asia Pacific Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion 119
Figure 84: Asia Pacific Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion) 122
Figure 85: Asia Pacific Antidepressant Drugs Market, Country Share, 2017 (% of Total) 124
Figure 86: Asia Pacific Antidepressant Drugs Market, Country Share, 2023 (% of Total) 124
Figure 87: India Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 126
Figure 88: India Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 126
Figure 89: Prevalence of Depressive Disorders in India By Age and Sex- (2015-2016) 127
Figure 90: India Healthcare Expenditure (2012-2016, USD Billion) 128
Figure 91: India Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 130
Figure 92: China Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 134
Figure 93: China Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 134
Figure 94: China YLDs by Anxiety Disorders (2013-2016 %) 135
Figure 95: China YLDs & DALYs by Depressive Disorders (2013-2016 %) 135
Figure 96: China Healthcare Expenditure (2012-2016, USD Billion) 136
Figure 97: China Population 65 Years & Above (% of Total), 2012-2016 136
Figure 98: China Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 137
Figure 99: Japan Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 140
Figure 100: Japan Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 140
14

15. List of Figures
Figure No. Figure Title Page No.
Figure 101: Japan Per Capita Health Expenditure (2012-2016, USD) 141
Figure 102: Japan YLDs by Depressive Disorders (2013-2016 %) 141
Figure 103: Japan YLDs by Depressive Disorders (2013-2016 %) 141
Figure 104: Japan Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 143
Figure 105: Rest of Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 145
Figure 106: Rest of Asia Pacific Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 145
Figure 107: Rest of World Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 147
Figure 108: Rest of World Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion) 148
Figure 109: Rest of World Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 150
Figure 110: Rest of World Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion) 153
Figure 111: Rest of World Antidepressant Drugs Market, Country Share, 2017 (% of Total) 155
Figure 112: Rest of World Antidepressant Drugs Market, Country Share, 2023 (% of Total) 155
Figure 113: Brazil Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 157
Figure 114: Brazil Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 157
Figure 115: Brazil Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 158
Figure 116: Saudi Arabia Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 161
15

16. List of Figures
Figure No. Figure Title Page No.
Figure 117: Saudi Arabia Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 162
Figure 118: Saudi Arabia Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 162
Figure 119: Others Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 164
Figure 120: Others Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 164
Figure 121: Pfizer Segmental Breakup, 2016 (%) 189
Figure 122: Pfizer Sales, By Region, 2016 (%) 189
Figure 123: Takeda Segmental Break Up 191
Figure 124: Takeda Geographical Break Up 191
Figure 125: Novartis Sales, By Segment 2015 (%) 194
Figure 126: Novartis Sales, By Region, 2015 (%) 194
Figure 127: Novartis Pharmaceuticals Sales, By Franchise, 2015 (%) 194
16

17. List of Tables
Table No. Table Title Page No.
Table A: List of Major Antidepressant Drugs Include in SSRIs Class 39
Table B: Licenced Indication of SSRIs 41
Table C: List of Major Antidepressant Drugs Include in SNRIs Class 43
Table D: List of Major Antidepressant Drugs Include in MAOIs Class 45
Table E: List of Major Antidepressant Drugs Include in Tricyclic Class 47
Table F: List of Major Antidepressant Drugs Include in Tetracyclic Class 47
Table G: List of Major Antidepressant Drugs Include in Benzodiazepines 48
Table H: List of Major Antidepressant Drugs Include in Antipsychotics 51
Table I: Antidepressant Drugs Market Analysis, By Drug, Developer, Phase, Indication 61
Table J: Facts and Figures Driving High Demand of Antidepressants in United States Market 81
17

18. Research Methodology
Research Definition
Global Antidepressant Drugs Market Report comprises of the study of various aspects of antidepressants and
forecast until 2023. Global Antidepressant Drugs Market has been segmented on basis of Drugs
Class(Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective -Norepinephrine Reuptake
Inhibitors, Monoamine Oxidase Inhibitors , Benzodiazepines Antipsychotics Novel Agents); By Sales Channels
(Hospital& Clinics, Retail Pharmacies, Others), By Region (North America, Europe, APAC, Middle East and ROW)
and By Country (U.S., Canada, Germany, United Kingdom, China, India, Japan, Brazil, Saudi Arabia,).
Data Analysis and Interpretation
Our historic market trend has been figured out by various paid databases which was further triangulated with
inputs and insights from industry experts, companies and stakeholders, through primary research
(manufacturers, marketing managers, others). Back-of-the-Envelope calculation for the market estimation has
been made through proper understanding of the market as well as future business strategies of the companies
operating in the market.
Azoth Analytics has conducted quantitative as well as qualitative research to gather market insights such as market sizing, market
segmentation, recent trends and developments and competitive landscape. Our team has conducted extensive primary surveys by
reaching out industry experts across the value chain of the global orthopeadic market.
Companies Contacted: Apollo Pharmacy
18

19. Global Antidepressant Drugs Market Overview
Source: Azoth Analytics Estimates
Xxxx
Xxxx
Xxxx
Xxxx
Xxxx
Xxxx
xxxx
Global Antidepressant Drugs Market has been driven by rising prevalence of depression and anxiety
disorders worldwide
2013 2014 2015 2016 2017
Figure : Global Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
CAGR 2013-2017
xxxx%
19

20. Figure : Global Monoamine Oxidase Inhibitors Antidepressant
Drugs Market, By Value, 2013-2017 (USD Billion)
Source: Azoth Analytics Estimates
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
Figure : Global Monoamine Oxidase Inhibitors Antidepressant
Drugs Market, By Value, 2018E-2023F (USD Billion)
Xxxxx
Xxxxx
Xxxxx
Xxxxx
Xxxxx
xxxxx
Global Monoamine Oxidase Inhibitors Antidepressant Drugs Market
Overview
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
20

21. Global Antidepressant Drugs Market - By Sales Channels
Figure: Global Antidepressant Drugs Market Size,
By Sales Channels, 2023 (%)
Source: Azoth Analytics Estimates
Key Drivers
Xxxxx
xxxxx
Xxxxx
xxxxx
Hospitals & Clinics
Retail Pharmacies
Others
In the forecast period, Retail Pharmacies are expected to account for the largest share in the market (45.34%)
but the Other segment estimated to be the faster growing region.
21

22. Source: Azoth Analytics Estimates
Figure : Germany Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
CAGR 2013-2017
TCAs: xx%; SSRIs: xx%; SNRIs; xx%;
MAOIs: xx%; Benzodiazepines: xx%;
Antipsychotics: xx%; Novel Agents: xx;
Others: xx%
Germany Antidepressant Drugs Market, By Drugs Class
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
22
CAGR 2018-2023
TCAs: xx%; SSRIs: xx%; SNRIs; xx%;
MAOIs: xx%; Benzodiazepines: xx%;
Antipsychotics: xx%; Novel Agents: xx;
Others: xx%

23. Source: Azoth Analytics Estimates
Figure 55: United States Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)
CAGR 2013-2017
TCAs: 1.82%; SSRIs: 2.75%; SNRIs;
2.82%; MAOIs: 1.83%; Benzodiazepines:
2.26%; Antipsychotics: 0.73%; Novel
Agents: 3.22%; Others:3.30%
United States Antidepressant Drugs Market, By Drugs Class
CAGR 2018-2023
TCAs: 2.42%; SSRIs: 3.20%; SNRIs;
3.23%; MAOIs: 2.36%; Benzodiazepines:
0.23%; Antipsychotics: 0.57%; Novel
Agents: 3.73%; Others:5.78 %
23
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Tricyclic Antidepressants (TCAs)
Selective Serotonin Reuptake (SSRIs)
Serotonin-Norepinephrine Reuptake Inhibitors
(SNRIs)
Monoamine Oxidase Inhibitors (MAOIs)
Benzodiazepines
Antipsychotics
Novel Agents
Others

24. About Azoth Analytics Pvt Ltd.
Azoth Analytics is a business research and analytics firm that creates in-depth research reports and provides customized research solutions and consultancy
services. Verticals in which Azoth Analytics specializes include healthcare and pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food &
beverages and technology. Azoth creates comprehensive and in-depth research reports by recording, interpreting and analyzing information. Strategic
market sizing and data dredging techniques include secondary research, and primary research (interviews with management personnel and industry experts).
Related Reports:
Global Vitreoretinal Surgery Devices Market (By Product, By End User, By Region, By Country): Opportunities and Forecast (2016-2021)
– By Product (Vitrectomy Machines & Packs, Photocoagulation Surgery Devices, Illumination Devices, Others); By End User (Hospitals, Free Standing
Ambulatory Surgery Center); By Region (North America, Europe, APAC, ROW); By Country (US, Canada, Mexico, UK, Germany, France, Japan, China,
India, Brazil, South Africa)
Global Biomaterials Market (By Type, By Applications, By Region): Opportunities and Forecasts (2016-2021) - (By Material Type – Polymer,
Ceramic, Metal; By Appliactions - Orthopaedic, Cardiovascular, Plastic Surgery, Wound Care); By Region-North America, Europe, APAC, ROW; By Country
– US, UK, Germany, Italy, Japan, China, India; Key Players – Strategy, Financial Performance)
Disclaimer: Azoth Analytics report information is based mainly on interviews and therefore, is subject to fluctuation. Azoth Analytics therefore, takes no responsibility for
any incorrect information supplied to us by industry experts, manufacturers or users. Azoth does not warranty the completeness of the information and data. Also, analysis
provided in the report are meant for customers’ internal use only and not for general publication or disclosure to third parties.
24